Blog

Trademark infringement on Amazon surged 62% YoY in 2025, with counterfeit listings costing brands $120B+ globally. From hijacked listings to counterfeit ASINs, unauthorized sellers exploit Amazon’s marketplace—but new legal precedents and tools empower brands to fight back. This guide reveals how to protect your IP and secure compensation. 🔍 I. 2025 Trademark Infringement Tactics: Know […]

Commercial disputes between U.S. and Chinese companies surged 47% YoY in 2024, driven by contract breaches, IP theft, and supply-chain conflicts. For businesses caught in this crossfire, understanding the cost of hiring a US-China commercial litigation lawyer is critical. This guide breaks down 2025 fee structures, hidden expenses, and tactics to slash costs by 30–60%.

Chinese companies face 870+ annual lawsuits in U.S. courts, but China’s judiciary now offers a powerful weapon: Anti-Suit Injunctions (ASIs). Post-2024 rulings like Huawei v. Netgear and Ericsson v. Samsung empower Chinese courts to freeze U.S. litigation with fines up to ¥1M/day ($139,675). Here’s how to deploy ASIs strategically. I. Legal Basis for ASIs in

Chinese companies face 870+ annual patent lawsuits in U.S. courts—a 31% YoY surge—with ITC 337 investigations targeting 50% of exporters . As U.S. plaintiffs exploit relaxed rules like the Lashify decision (2025) and “Schedule A” TRO freezes, victory demands surgical countermeasures. Here’s how we turn U.S. legal weapons against accusers. 🛡️ 1. Crush Patent Validity

Patent defendants face a 67% loss rate in U.S. district courts—but in 2025, new tactics flip the odds. Post-Lashify, plaintiffs exploit weakened “domestic industry” rules to fast-track ITC complaints, while SAD lawsuits freeze e-commerce revenues overnight. Here’s how to dismantle patent claims before discovery ends. Step 1: Annihilate Patent Validity (Days 1-30) Tactics: File IPR/PGR

Chinese companies face 870+ annual patent suits in US courts—a 31% YoY surge—with ITC 337 investigations now targeting 50% of Chinese exporters. As US plaintiffs weaponize Lashify-relaxed domestic industry rules and SAD lawsuits for bulk TRO freezes, victory demands surgical countermeasures. Here’s how we turn US legal weapons against accusers. 1. ITC 337 Investigations: Crushing

The convergence of U.S.-China trade tensions and regulatory escalation demands integrated legal strategies. With China’s State Council Order No. 801 (2025) enabling retaliatory IP measures and U.S. courts awarding triple damages for willful infringement, businesses and individuals face unprecedented risks. Here’s how to dominate five critical battlefields. 🛡️ 1. China-US IP Litigation: Turning Retaliation into

The escalating U.S.-China legal tensions demand specialized strategies across intellectual property (IP), regulatory compliance, and personal law. With China’s State Council Order No. 801 (2025) empowering retaliatory measures against “discriminatory foreign IP actions” , and U.S. “337 investigations” hitting Chinese firms with 60% loss rates , businesses and individuals require tactical navigation. Here’s how to

The 2025 Federal Circuit decision in Lashify, Inc. v. ITC revolutionized ITC practice by expanding the domestic industry requirement. Complainants can now satisfy the economic prong through investments in sales, marketing, and distribution—not just manufacturing or R&D. For respondents, this demands three countermeasures: 1. Challenge “Significant Investment” Threshold: Argue that the complainant’s expenditures (e.g., warehousing

The extension of China’s suspension on US agricultural tariff exemptions (effective Aug 1, 2025) marks a new phase in US-China trade tensions. With beef tariffs potentially surging from 32% to 70% and punitive measures expanding beyond traditional sectors, businesses require adaptive frameworks to navigate cascading risks. This analysis synthesizes actionable strategies from recent enforcement cases